KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Illumina (ILMN) EBITDA (2016 - 2026)

Illumina filings provide 18 years of EBITDA readings, the most recent being $209.0 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 27.44% to $209.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $851.0 million, a 252.78% increase, with the full-year FY2025 number at $807.0 million, up 196.88% from a year prior.
  • EBITDA hit $209.0 million in Q1 2026 for Illumina, up from $201.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $741.0 million in Q3 2024 to a low of -$4.0 billion in Q1 2023.
  • Median EBITDA over the past 5 years was -$64.0 million (2023), compared with a mean of -$526.7 million.
  • Biggest five-year swings in EBITDA: tumbled 1760.23% in 2024 and later surged 247.75% in 2025.
  • Illumina's EBITDA stood at -$3.7 billion in 2022, then soared by 95.52% to -$164.0 million in 2023, then soared by 206.71% to $175.0 million in 2024, then rose by 14.86% to $201.0 million in 2025, then increased by 3.98% to $209.0 million in 2026.
  • The last three reported values for EBITDA were $209.0 million (Q1 2026), $201.0 million (Q4 2025), and $227.0 million (Q3 2025) per Business Quant data.